维普中文期刊产品整合服务
19篇 您的检索式:作者名="Dryden MS"
    题名 作者 年代 出处 被引量
1Linezolid pharmacokinetics and pharmacody- namics in clinical treatment显示文摘Dryden MS 2011J Antimicrob Chemother2011,66,4:1
2Comparative activity of ceftobiprole against Gram - positive andGram - negative isolates from Europe and the Middle East : theCLASS study 显示文摘ROSSOLINI GM DRYDEN MS KOZLOV RS 2011J Antimicrob Chemother2011,66,1:1
3Complicated skin and soft tissue infection 显示文摘Dryden MS 2010J Antimicrob Chemother2010,65,3:1
4Skin and soft tissue infection: microbiology and epide- miology显示文摘Dryden MS 2009Int J Antimicrob Agents2009,34,1:1
5Empirical treatment of severe a- cute community-acquired gastroenteritis with ciprofloxacin显示文摘Dryden MS Gabb RJ Wright sK 1996Clin Infect Dis1996,22,6:1
6Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus显示文摘Itani KM Dryden MS Bhattacharyya H 2010Am J Surg2010,199,6:1
7Linezolid pharmacokinetics and pharmacodynamics in clinical treatment显示文摘Dryden MS 0,,14:1
8Linezolid pharmacokinetics and pharmacody- namics in Clinical treatment 显示文摘Dryden MS 2011JAntimicrob Chemother2011,66,4:1
9Linezolid pharmacokinetics and pharmaco-dynamics in clinical treatment显示文摘Dryden MS 2011J Antimicrob Chemother2011,66,4:1
10Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue inteetions proven to be caused by methieillin-resistant Staphylococcus aureus显示文摘ITANI KM DRYDEN MS BHATTACHARYYA H 2010Am J Surg2010,199,6:1
11Linezolid pharmacokinetics and pharmacody- namics in clinical treatment显示文摘Dryden MS 2011J Antimicrob Chemother2011,66,4:1
12Eflqcacy and safety of linezolid versus vaneomycin for the treatment of complicated skin and soft - tissue infections proven to be caused by methicilli- nresistantStaphyloeoccus aureus 显示文摘Itani KM Dryden MS Bhattacharyya H 2010Am J Surg2010,199,6:1
13Linezolid pharmacokinetics and pharmacodynamics in clinical treatment显示文摘Dryden MS 2011J Antimicrob Chemother2011,66,4:1
14Skin and soft tissue infection: microbiology and epidemioIogy显示文摘Dryden MS 2009Int Anti-microb Agents2009,34,1:1
15Infective complications associated with the use of Quinton Permcath for longterm central vascular access in haemodialysis显示文摘Dryden MS Samson A Ludlam HA 1991J Hosp Infect1991,19,4:1
16Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus显示文摘Itani KM Dryden MS Bhattacharyya H 2010Am J Surg2010,199,6:1
17Linezolid pharmacokinetics and phamlacodynamics in clinical treatment 显示文摘Dryden MS 2011J Antimicrob Chemother2011,,4:1
18Antibiotic stewardship more education and regulation not more availability显示文摘DRYDEN MS COOKJ DAVEY P 2009Antimicrob Chemother2009,64,5:1
19Active intervention dramatically reduces CAPD associated infection显示文摘Dryden MS Ludlam HA Wing AJ 1991Adv Peri Dial1991,7,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费